Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
ONO PHARMA, Last Fiscal Year Net Income Revised Downward by 14%
4528 ONO PHARMACEUTICAL CO., LTD. 【IFRS】
Guidance Update ReportONO PHARMACEUTICAL CO., LTD. <4528> [TSE Prime] announced a performance revision after the market closed on April 28th (16:00). The consolidated net income for the fiscal year ending March 2025 has decreased 13.8%, from the previous forecast of 58 billion yen to 50 billion yen (compared to 127 billion yen in the previous period), leading to an increase in the profit decline rate from 54.7% to 60.9%.
Based on the downwardly revised full-year plan announced by the company, our calculation indicates that the October to March period (2H) consolidated net income has decreased 48.9%, from the previous forecast of 16.3 billion yen to 8.35 billion yen (compared to 53.4 billion yen in the same period of the previous year), leading to an increase in the profit decline rate from 69.4% to 84.4%.
Kabutan News
Guidance Update
Second Half Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2024 Prev | 244,661 | 26,119 | 26,863 | 16,359 | 34.8 | 40 | Oct 31, 2024 | IFRS |
Oct - Mar, 2024 New | 246,661 | 4,119 | 5,363 | 8,359 | 17.8 | 40 | Apr 28, 2025 | IFRS |
Revision Rate | +0.8% | -84.2% | -80.0% | -48.9% | -48.9% |
Full Year Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2025 Prev | 485,000 | 82,000 | 81,500 | 58,000 | 123.5 | 80 | Oct 31, 2024 | IFRS |
Mar, 2025 New | 487,000 | 60,000 | 60,000 | 50,000 | 106.5 | 80 | Apr 28, 2025 | IFRS |
Revision Rate | +0.4% | -26.8% | -26.4% | -13.8% | -13.8% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 243,959 | 62,899 | 64,438 | 53,486 | 111.4 | 40 | May 9, 2024 | IFRS |
Oct - Mar, 2024 Guidance | 246,661 | 4,119 | 5,363 | 8,359 | 17.8 | 40 | Apr 28, 2025 | IFRS |
YoY | +1.1% | -93.5% | -91.7% | -84.4% | -84.0% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 447,187 | 141,963 | 143,532 | 112,723 | 230.9 | 70 | May 10, 2023 | IFRS |
Mar, 2024 | 502,672 | 159,935 | 163,734 | 127,977 | 266.6 | 80 | May 9, 2024 | IFRS |
Mar, 2025 Guidance | 487,000 | 60,000 | 60,000 | 50,000 | 106.5 | 80 | Apr 28, 2025 | IFRS |
YoY | -3.1% | -62.5% | -63.4% | -60.9% | -60.1% |
Related Articles
Kushim, Last Fiscal Year's Net Income Loss Narrows, Current period performance is undisclosed.
NIHON KOGYO, 2% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 5 yen
TSURUYA, Last Fiscal Year Ordinary Profit Revised Downward by 11%, Dividend Revised down by 2 yen
Financial Products Group, First Half Ordinary Profit Decreases by 1%
TOYO SECURITIES, 28% Decrease in Ordinary Profit for the Last Fiscal Year, Current period performance is undisclosed.
Lasertec, Jan-Mar (3Q) Ordinary Profit Decreases by 53%
HOKURIKU ELECTRICAL CONSTRUCTION, 9% Decrease in Ordinary Profit for The Current Fiscal Year
XEBIO, Last Fiscal Year Ordinary Profit Revised Upward by 21%, Dividend Revised Upward by 2.5 yen
ORIENTAL LAND, 7% Decrease in Ordinary Profit for The Current Fiscal Year
NIPPON SHARYO, 19% Decrease in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 5 yen, This Fiscal Year to Increase Dividend by 5 yen